PD Kottaridis

643 total citations
19 papers, 428 citations indexed

About

PD Kottaridis is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, PD Kottaridis has authored 19 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in PD Kottaridis's work include Hematopoietic Stem Cell Transplantation (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). PD Kottaridis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). PD Kottaridis collaborates with scholars based in United Kingdom, Germany and Cyprus. PD Kottaridis's co-authors include R Chatterjee, Stephen Mackinnon, AH Goldstone, Ronjon Chakraverty, DC Linch, A. V. Hoffbrand, Veronique Duke, P Mahendra, Mary M. Reilly and Karl S. Peggs and has published in prestigious journals such as Blood, Clinical Pharmacology & Therapeutics and Leukemia.

In The Last Decade

PD Kottaridis

19 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
PD Kottaridis United Kingdom 13 191 103 99 88 62 19 428
A. O’Meara Ireland 13 207 1.1× 139 1.3× 189 1.9× 105 1.2× 136 2.2× 20 872
Vera Otten Netherlands 5 238 1.2× 97 0.9× 60 0.6× 71 0.8× 31 0.5× 7 435
C Rozmán Spain 10 133 0.7× 69 0.7× 72 0.7× 99 1.1× 39 0.6× 58 440
Marta Rozans United States 8 140 0.7× 87 0.8× 51 0.5× 39 0.4× 53 0.9× 13 465
Deva Sharma United States 13 165 0.9× 231 2.2× 102 1.0× 161 1.8× 78 1.3× 39 598
Dimitrios Margaritis Greece 11 246 1.3× 138 1.3× 147 1.5× 80 0.9× 26 0.4× 36 598
Thomas Loew United States 9 206 1.1× 88 0.9× 105 1.1× 30 0.3× 116 1.9× 14 623
Michael Salacz United States 9 114 0.6× 168 1.6× 112 1.1× 101 1.1× 46 0.7× 20 469
Hasan Hashem Jordan 12 106 0.6× 64 0.6× 65 0.7× 100 1.1× 23 0.4× 38 392
Lulin Choubtum Thailand 11 124 0.6× 161 1.6× 69 0.7× 53 0.6× 79 1.3× 22 454

Countries citing papers authored by PD Kottaridis

Since Specialization
Citations

This map shows the geographic impact of PD Kottaridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PD Kottaridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PD Kottaridis more than expected).

Fields of papers citing papers by PD Kottaridis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PD Kottaridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PD Kottaridis. The network helps show where PD Kottaridis may publish in the future.

Co-authorship network of co-authors of PD Kottaridis

This figure shows the co-authorship network connecting the top 25 collaborators of PD Kottaridis. A scholar is included among the top collaborators of PD Kottaridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PD Kottaridis. PD Kottaridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Davies, Andrea, Athina Giannoudis, L Wang, et al.. (2014). Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia. Clinical Pharmacology & Therapeutics. 96(6). 694–703. 12 indexed citations
2.
Stewart, Wendy A., Rachel Pearce, Keiren Kirkland, et al.. (2010). The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study. Bone Marrow Transplantation. 45(11). 1587–1593. 47 indexed citations
3.
Goulding, Carol, Ben Uttenthal, Letizia Foroni, et al.. (2007). The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis. International Journal of Laboratory Hematology. 30(5). 415–419. 25 indexed citations
4.
Steele, Andrew J., Dylan T. Jones, K. Ganeshaguru, et al.. (2006). The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia. 20(6). 1073–1079. 63 indexed citations
5.
Kottaridis, PD, Joseph Eliahoo, H H McGarrigle, et al.. (2003). Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. Bone Marrow Transplantation. 31(1). 45–50. 21 indexed citations
6.
Chatterjee, R & PD Kottaridis. (2002). Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies. Bone Marrow Transplantation. 30(10). 629–635. 39 indexed citations
7.
Kottaridis, PD, Karl S. Peggs, Norbert Schmitz, et al.. (2002). Survival and Freedom from Progression in Autotransplant Lymphoma Patients is Independent of Stem Cell Source: Further Follow-up from the Original Randomised Study to Assess Engraftment. Leukemia & lymphoma. 43(3). 531–536. 2 indexed citations
8.
9.
Paneesha, Shankaranarayana, PD Kottaridis, Ronjon Chakraverty, et al.. (2002). Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplantation. 30(6). 401–404. 48 indexed citations
10.
Kottaridis, PD, DW Milligan, Charles Craddock, et al.. (2001). Non-myeloablative transplantation for patients with Hodgkin's disease: Limited transplant related mortality and possible evidence of a graft versus Hodgkin's effect.. UCL Discovery (University College London). 4 indexed citations
11.
12.
Chatterjee, R, et al.. (2001). Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies. Bone Marrow Transplantation. 28(5). 497–502. 19 indexed citations
13.
Chakraverty, Ronjon, Stephen Robinson, Karl S. Peggs, et al.. (2001). Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation. Bone Marrow Transplantation. 28(9). 827–834. 27 indexed citations
14.
Kottaridis, PD, Karl S. Peggs, Anthony J. Lawrence, et al.. (2000). One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and β-thalassaemia major: potential cure of both marrow disorders. Bone Marrow Transplantation. 25(6). 677–678. 9 indexed citations
15.
16.
Kottaridis, PD, K Peggs, Stephen Devereux, AH Goldstone, & Stephen Mackinnon. (2000). Simultaneous occurrence of Clostridium difficile and Cytomegalovirus colitis in a recipient of autologous stem cell transplantation.. PubMed. 85(10). 1116–7. 5 indexed citations
17.
Kottaridis, PD, D W Milligan, Sakti Chakrabarti, et al.. (1999). A non myeloablative regimen for allografting high-risk patients: Low toxicity, stable engraftment without GVHD, disease control and potential for GVL with adoptive immunotherapy.. Blood. 94(10). 109039–109039. 6 indexed citations
18.
19.
Kottaridis, PD, Howard D. Rees, Graham A. Smith, et al.. (1999). A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation. Bone Marrow Transplantation. 23(7). 739–741. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. O’Meara Breakdown of academic impact, for papers by Vera Otten Breakdown of academic impact, for papers by C Rozmán Breakdown of academic impact, for papers by Marta Rozans Breakdown of academic impact, for papers by Deva Sharma Breakdown of academic impact, for papers by Dimitrios Margaritis Breakdown of academic impact, for papers by Thomas Loew Breakdown of academic impact, for papers by Michael Salacz Breakdown of academic impact, for papers by Hasan Hashem Breakdown of academic impact, for papers by Lulin Choubtum
Rankless by CCL
2026